448 related articles for article (PubMed ID: 36983063)
1. NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.
Jin BK; Odongo S; Radwanska M; Magez S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983063
[TBL] [Abstract][Full Text] [Related]
2. Nanobodies as molecular imaging probes.
Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B
Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292
[TBL] [Abstract][Full Text] [Related]
3. Mapping cytoskeletal protein function in cells by means of nanobodies.
Van Audenhove I; Van Impe K; Ruano-Gallego D; De Clercq S; De Muynck K; Vanloo B; Verstraete H; Fernández LÁ; Gettemans J
Cytoskeleton (Hoboken); 2013 Oct; 70(10):604-22. PubMed ID: 23818458
[TBL] [Abstract][Full Text] [Related]
4. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
5. Nanobodies: from structure to applications in non-injectable and bispecific biotherapeutic development.
Li B; Qin X; Mi LZ
Nanoscale; 2022 May; 14(19):7110-7122. PubMed ID: 35535618
[TBL] [Abstract][Full Text] [Related]
6. NANOBODY
Kunz S; Durandy M; Seguin L; Feral CC
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686035
[TBL] [Abstract][Full Text] [Related]
7. Nanobodies: The "Magic Bullets" in therapeutics, drug delivery and diagnostics.
Mir MA; Mehraj U; Sheikh BA; Hamdani SS
Hum Antibodies; 2020; 28(1):29-51. PubMed ID: 31322555
[TBL] [Abstract][Full Text] [Related]
8. Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma.
Bannas P; Koch-Nolte F
Front Immunol; 2018; 9():2559. PubMed ID: 30459772
[TBL] [Abstract][Full Text] [Related]
9. NanoBERTa-ASP: predicting nanobody paratope based on a pretrained RoBERTa model.
Li S; Meng X; Li R; Huang B; Wang X
BMC Bioinformatics; 2024 Mar; 25(1):122. PubMed ID: 38515052
[TBL] [Abstract][Full Text] [Related]
10. INDI-integrated nanobody database for immunoinformatics.
Deszyński P; Młokosiewicz J; Volanakis A; Jaszczyszyn I; Castellana N; Bonissone S; Ganesan R; Krawczyk K
Nucleic Acids Res; 2022 Jan; 50(D1):D1273-D1281. PubMed ID: 34747487
[TBL] [Abstract][Full Text] [Related]
11. Nanobody engineering for SARS-CoV-2 neutralization and detection.
Hannula L; Kuivanen S; Lasham J; Kant R; Kareinen L; Bogacheva M; Strandin T; Sironen T; Hepojoki J; Sharma V; Saviranta P; Kipar A; Vapalahti O; Huiskonen JT; Rissanen I
Microbiol Spectr; 2024 Apr; 12(4):e0419922. PubMed ID: 38363137
[TBL] [Abstract][Full Text] [Related]
12. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
Liu B; Yang D
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
[TBL] [Abstract][Full Text] [Related]
13. Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies.
Khodabakhsh F; Behdani M; Rami A; Kazemi-Lomedasht F
Int Rev Immunol; 2018; 37(6):316-322. PubMed ID: 30741045
[TBL] [Abstract][Full Text] [Related]
14. Application Progress of the Single Domain Antibody in Medicine.
Tang H; Gao Y; Han J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835588
[TBL] [Abstract][Full Text] [Related]
15. [Progress in nanobody and its application in diagnosis].
Kong Q; Yao Y; Chen R; Lu S
Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
[TBL] [Abstract][Full Text] [Related]
16. Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.
Arbabi-Ghahroudi M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563400
[TBL] [Abstract][Full Text] [Related]
17. Nanobodies: a promising approach to treatment of viral diseases.
Minatel VM; Prudencio CR; Barraviera B; Ferreira RS
Front Immunol; 2023; 14():1303353. PubMed ID: 38322011
[TBL] [Abstract][Full Text] [Related]
18. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
[TBL] [Abstract][Full Text] [Related]
19. Generation of a CD70-Specific Fusion Nanobody with IgG Recruiting Capacity for Tumor Killing.
Liu C; Li J; Hu Q; Xu X; Zhang X
Int J Nanomedicine; 2023; 18():3325-3338. PubMed ID: 37361386
[TBL] [Abstract][Full Text] [Related]
20. [Application of nanobody in cancer treatment].
Wu Y; Hao X; Li M
Sheng Wu Gong Cheng Xue Bao; 2017 Jul; 33(7):1085-1090. PubMed ID: 28869728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
